hydroxyurea has been researched along with 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, X; Ganta, M; Grzeschik, SM; Wang, CH; Xu, C | 1 |
Almeida, CB; Conran, N; Costa, FF; Costa, FT; Covas, DT; Leonardo, FC; Souza, LE; Werneck, CC | 1 |
2 other study(ies) available for hydroxyurea and 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide
Article | Year |
---|---|
Hydroxyurea enhances SMN2 gene expression through nitric oxide release.
Topics: Base Sequence; Cell Line; Cyclic N-Oxides; DNA Primers; Free Radical Scavengers; Gene Expression; Humans; Hydroxyurea; Imidazoles; Lymphocytes; Muscular Atrophy, Spinal; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival of Motor Neuron 2 Protein | 2011 |
Acute hemolytic vascular inflammatory processes are prevented by nitric oxide replacement or a single dose of hydroxyurea.
Topics: Anemia, Sickle Cell; Animals; Cell Movement; Cyclic N-Oxides; Disease Models, Animal; Free Radical Scavengers; Hemoglobins; Hemolysis; Humans; Hydrazines; Hydroxyurea; Imidazoles; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nitric Oxide; Nitric Oxide Donors; Primary Cell Culture; Tumor Necrosis Factor-alpha; Viscosity; Water | 2015 |